The delivery of clinical care has been subject to unprecedented change over the last two years, with the pandemic requiring new formats and approaches to be trialled at speed. We’re now in a position where learnings made during the pandemic can influence the future makeup of clinical MS care, and there’s an opportunity to embed patient preferences in the design of future services.
In 2021 we surveyed over 2,000 community members to capture MSer preferences about their future clinical care.
Our findings highlight virtual or remote care as being hugely beneficial, but not a cure-all. These unique insights provide an unprecedented opportunity to invite the voice of the MS community ‘into the room’ when you shape your services for the future.
Access to MS clinical care in general
Experience with remote or virtual MS clinical care
Preferences around the future of MS clinical care
Shift.ms would like to thank all the MSers who took the time to provide their feedback on the survey and for sharing their experiences. We would like to thank the Neurology Academy for endorsing the survey and providing clinical feedback. Finally, we would like to thank Biogen, Bristol Myers Squibb, Merck, Novartis and Roche for supporting this project.